Peter Sampson

Peter has over 20 years of drug development experience including discovery chemistry, CMC regulatory affairs and IP portfolio management. Peter joined GeneTether from Scientus Pharma where he served as the Director of Research and Development at Scientus Pharma and led the advancement of their extraction technology through to commercialization. Prior to Scientus Pharma, Peter spent 10 years as a Scientist in the Therapeutics Group at the University Health Network (UHN) where he was involved in discovery research and led the CMC development programs for their PLK4, TTK and HPK1 clinical candidates. Prior to UHN, Peter held various R&D leadership roles of increasing responsibility at Affinium Pharmaceuticals, GlycoDesign Inc. and Albany Molecular Research Inc.

Peter holds a BSc in Chemistry from St. Mary’s University and an MSc and PhD degrees in Organic Chemistry from the University of Waterloo. He is the co-author of 20 scientific publications and an inventor on over 20 patents.